Iodine-131

solute carrier family 5 member 5 ; Homo sapiens







85 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33511173 Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study. 2021 Jan 6 1
2 33831503 The flavonoid quercetin reduces cell migration and increases NIS and E-cadherin mRNA in the human thyroid cancer cell line BCPAP. 2021 Jun 1 1
3 33974556 Na+/I- symporter expression, function, and regulation in non-thyroidal tissues and impact on thyroid cancer therapy. 2021 Sep 3 1
4 34199867 MiR-181a-5p Regulates NIS Expression in Papillary Thyroid Carcinoma. 2021 Jun 4 1
5 34771624 Analysis of NIS Plasma Membrane Interactors Discloses Key Regulation by a SRC/RAC1/PAK1/PIP5K/EZRIN Pathway with Potential Implications for Radioiodine Re-Sensitization Therapy in Thyroid Cancer. 2021 Oct 30 6
6 33009242 Combination of peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists induces sodium/iodide symporter expression and inhibits cell growth of human thyroid cancer cells. 2020 Oct 1
7 31061881 A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression. 2019 Jun 28 2
8 31119602 NES1/KLK10 and hNIS gene therapy enhanced iodine-131 internal radiation in PC3 proliferation inhibition. 2019 Dec 1
9 29298843 NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features. 2018 Jan 2
10 29467904 Human sodium iodide transporter gene-mediated imaging and therapy of mouse glioma, comparison between 188Re and 131I. 2018 Mar 3
11 28386277 Thyroid-Related Protein Expression in the Human Thymus. 2017 1
12 26838744 Effects of BRAF(V600E) mutation on Na(+)/I(-) symporter expression in papillary thyroid carcinoma. 2016 Feb 2
13 27363025 Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy. 2016 Aug 23 1
14 25410753 Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy. 2015 Jan 1
15 25615643 Experimental study of nasopharyngeal carcinoma radionuclide imaging and therapy using transferred human sodium/iodide symporter gene. 2015 1
16 25773964 A novel hNIS/tdTomato fusion reporter for visualizing the relationship between the cellular localization of sodium iodide symporter and its iodine uptake function under heat shock treatment. 2015 1
17 25955347 Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer. 2015 Jul 2
18 25960292 Inhibition of miR-146b expression increases radioiodine-sensitivity in poorly differential thyroid carcinoma via positively regulating NIS expression. 2015 Jul 10 3
19 26397139 Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin. 2015 Oct 13 1
20 26599396 Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake. 2015 5
21 24353283 Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. 2014 Apr 1
22 24369144 Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter. 2014 Jan-Feb 2
23 24708099 NIS mediates iodide uptake in the female reproductive tract and is a poor prognostic factor in ovarian cancer. 2014 Jul 1
24 24835528 Remission of disseminated cancer after systemic oncolytic virotherapy. 2014 Jul 3
25 24884806 Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer. 2014 Apr 30 2
26 24898835 Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets. 2014 Oct 3
27 25309780 Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology. 2014 Sep 1
28 23038026 Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus. 2013 Jun 1
29 23404348 Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene. 2013 Apr 2
30 23420532 The glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant glioma. 2013 Feb 2
31 22355179 Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells. 2012 Jun 1
32 22412937 SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I. 2012 2
33 22790962 Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy. 2012 Sep 1
34 23037808 A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer. 2012 Dec 2
35 21209020 KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells. 2011 Mar 1
36 21386735 Feasibility of a novel positive feedback effect of 131I-promoted Bac-Egr1-hNIS expression in malignant glioma through baculovirus: a comparative study with Bac-CMV-hNIS. 2011 May 2
37 21471848 Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma. 2011 Jul 1
38 21499816 Expression and localization of the sodium/iodide symporter (NIS) in testicular cells. 2011 Aug 1
39 21531298 Feasibility of a novel positive feedback effect of 131I-promoted Bac-Egr1-hNIS expression in malignant glioma via baculovirus. 2011 May 12
40 21797672 Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells. 2011 Aug 2
41 21801606 Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells. 2011 Aug 3
42 21989294 Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer. 2011 Oct 11 2
43 22234102 Sodium iodide symporter, estrogen receptor, and progesterone receptor expression in carcinoma breast--an immunohistochemical analysis. 2011 Oct-Dec 1
44 20053774 Human sodium/iodide symporter-mediated radioiodine gene therapy enhances the killing activities of CTLs in a mouse tumor model. 2010 Jan 1
45 20228127 Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells. 2010 Jun 6
46 20428214 A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer. 2010 Nov 4
47 20683361 Sodium butyrate enhances the expression of baculovirus-mediated sodium/iodide symporter gene in A549 lung adenocarcinoma cells. 2010 Oct 1
48 21089675 [Radioiodide treatment mediated by adenovirus transfer of human sodium iodide symporter gene into androgen-independent prostate cancer]. 2010 Oct 1
49 21204761 Human sodium iodide symporter added to multidrug resistance 1 small hairpin RNA in a single gene construct enhances the therapeutic effects of radioiodine in a nude mouse model of multidrug resistant colon cancer. 2010 Dec 1
50 24899932 Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma. 2010 Apr 1